Volume changes in gray matter in patients with schizophrenia

Hilleke E. Hulshoff Pol, Hugo G. Schnack, Madelief G.B.C. Bertens, Neeltje E.M. Van Haren, Ingeborg Van der Tweel, Wouter G. Staal, Wim F.C. Baaré, René S. Kahn

Research output: Contribution to journalArticlepeer-review

184 Scopus citations

Abstract

Objective: Schizophrenia is generally characterized by a progressive decline in functioning. Although structural brain abnormalities, particularly decrements in gray matter volume, are considered important to the pathology of schizophrenia, it is not resolved whether the brain abnormalities become more prominent over time. Method: Magnetic resonance brain images from 159 patients with schizophrenia and 158 healthy comparison subjects between 16 and 70 years of age were compared. Using linear regression analysis, the authors analyzed the relationship between the volumes of the total brain, gray and white matter, cerebellum, and lateral and third ventricles with patient age. Results: Total brain (-2.2%), cerebral gray matter (-3.3%), prefrontal gray matter (-4.4%), and prefrontal white matter (-3.5%) volumes were smaller, and lateral (27%) and third (30%) ventricle and peripheral CSF (11%) volumes were larger in schizophrenia patients. A significant group-by-age interaction for gray matter volume was found, as shown by a steeper regression slope between age and gray matter volume in patients (-3.43 ml/year) than in healthy comparison subjects (-2.74 mi/ year). Conclusions: The smaller brains of the patients with schizophrenia can be explained by decreases in gray matter volume. Moreover, the finding that the smaller gray matter volume was more pronounced in older patients with schizophrenia may suggest progressive loss of cerebral gray matter in schizophrenia patients.

Original languageEnglish
Pages (from-to)244-250
Number of pages7
JournalAmerican Journal of Psychiatry
Volume159
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Dive into the research topics of 'Volume changes in gray matter in patients with schizophrenia'. Together they form a unique fingerprint.

Cite this